- Home
- KLRS vs EDHL Comparison
KLRS vs EDHL Comparison
Compare KLRS & EDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- EDHL
- Stock Information
- Founded
- KLRS 2019
- EDHL 2021
- Country
- KLRS United States
- EDHL Hong Kong
- Employees
- KLRS N/A
- EDHL N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- EDHL
- Sector
- KLRS Health Care
- EDHL
- Exchange
- KLRS Nasdaq
- EDHL NYSE
- Market Cap
- KLRS 129.0M
- EDHL 137.6M
- IPO Year
- KLRS N/A
- EDHL 2025
- Fundamental
- Price
- KLRS $2.50
- EDHL $5.75
- Analyst Decision
- KLRS Buy
- EDHL
- Analyst Count
- KLRS 1
- EDHL 0
- Target Price
- KLRS N/A
- EDHL N/A
- AVG Volume (30 Days)
- KLRS 38.9K
- EDHL 2.5M
- Earning Date
- KLRS 08-15-2025
- EDHL 01-01-0001
- Dividend Yield
- KLRS N/A
- EDHL N/A
- EPS Growth
- KLRS N/A
- EDHL N/A
- EPS
- KLRS N/A
- EDHL 0.14
- Revenue
- KLRS N/A
- EDHL $2,761,798.00
- Revenue This Year
- KLRS N/A
- EDHL N/A
- Revenue Next Year
- KLRS N/A
- EDHL N/A
- P/E Ratio
- KLRS N/A
- EDHL $30.01
- Revenue Growth
- KLRS N/A
- EDHL N/A
- 52 Week Low
- KLRS $2.28
- EDHL $3.51
- 52 Week High
- KLRS $24.15
- EDHL $6.88
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- EDHL N/A
- Support Level
- KLRS N/A
- EDHL N/A
- Resistance Level
- KLRS N/A
- EDHL N/A
- Average True Range (ATR)
- KLRS 0.00
- EDHL 0.00
- MACD
- KLRS 0.00
- EDHL 0.00
- Stochastic Oscillator
- KLRS 0.00
- EDHL 0.00
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About EDHL EVERBRIGHT DIGITAL HOLDING
Everbright Digital Holding Ltd is an integrated marketing solutions provider in Hong Kong that is involved in the metaverse and related technologies, and is providing one-stop digital marketing services for the process of enterprise development. Its digital marketing solutions include metaverse stimulation, virtual reality (VR) and augmented reality (AR) design and creation, creative event planning and management, IP character creation and social media marketing.